Rankings
▼
Calendar
AMRN FY 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$583M
-5.0% YoY
Gross Profit
$462M
79.2% margin
Operating Income
$11M
1.8% margin
Net Income
$8M
1.3% margin
EPS (Diluted)
$0.38
Cash Flow
Operating Cash Flow
-$67M
Free Cash Flow
-$67M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$401M
Stockholders' Equity
$667M
Cash & Equivalents
$219M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$583M
$614M
-5.0%
Gross Profit
$462M
$483M
-4.3%
Operating Income
$11M
-$20M
+153.4%
Net Income
$8M
-$18M
+142.9%
← Q4 2020
All Quarters
Q1 2021 →